Exact Sciences and Mayo Clinic initiate 150,000 patient, 7-year Cologuard® study
Exact Sciences announced it has initiated a collaboration with Mayo Clinic to generate evidence of the real-world impact of Cologuard on colorectal cancer screening, incidence, and mortality rates. Voyage is a prospective, observational study designed to enroll more than 150,000 people. October 14, 2019